Brugada Syndrome in the Pediatric Population: Diagnostic Challenges and Clinical Outcome—Results of the German Multicenter Study COGIA
Open Access
- 30 August 2026
- journal article
- research article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (11) , 2638-2650
Abstract
Introduction: Diagnosis and treatment of children and adolescents with suspected Brugada syndrome (BrS) is challenging. Aim of the study was to evaluate the applicability of current diagnostic criteria for pediatric patients with suspected BrS in the German multicenter study COGIA and to assess clinical outcome. Methods: Data analysis of 76 pediatric patients from 12 German tertiary care centers. Primary outcome was defined by the occurrence of a major arrhythmic event (MAE), secondary outcome by symptoms, pharmacotherapy and implantation of devices. MAE was defined as sudden cardiac death (SCD), aborted cardiac arrest (ACA) and appropriate implantable cardioverter‐defibrillator (ICD) therapy. Results: Criteria for BrS diagnosis were fulfilled in 39/76 pediatric patients (51.3%) according to ESC Guidelines, including 34 patients (44.7%) according to Shanghai Score. Genetic testing identified a (likely) pathogenic SCN5A variant in 31/66 tested children (47.0%) (14/30 with clinical diagnosis (46.7%) and 17/36 without clinical diagnosis (47.2%)). Twenty‐four patients (31.6%) showed a spontaneous type 1 ECG pattern, in 6 patients (7.9%) it was induced by fever. Ajmaline challenge was positive in 19/25 patients (76.0%). Syncope occurred in 15 patients (19.7%) and an ICD was implanted in 7 pediatric patients (9.2%). Four patients (5.3%) experienced a MAE (ACA), all of them fulfilling diagnostic criteria. “Symptoms at first consultation” was identified as an independent risk factor for MAE in the whole cohort (HR = 11.3, p = 0.04). Conclusion: Establishing the diagnosis of BrS remains challenging in the pediatric cohort. MAE occurred in 5.3% of patients with suspected BrS. Symptoms at first consultation increased risk for MAE. Clinical Trial Registration: The study is registered at the German Clinical Trial Register (DRKS) of the Federal Institute for Drugs and Medical Devices (BfArM), DRKS‐ID DRKS00028138.Keywords
This publication has 28 references indexed in Scilit:
- Epidemiology of paediatric inherited arrhythmogenic diseases under “Real World” conditions: findings from a 10-year longitudinal study in Eastern AustriaEuropean Journal of Pediatrics, 2025
- Current gaps in knowledge in inherited arrhythmia syndromesNetherlands Heart Journal, 2023
- Screening, diagnosis and follow-up of Brugada syndrome in children: a Dutch expert consensus statementNetherlands Heart Journal, 2022
- Fever-related arrhythmic events in the multicenter Survey on Arrhythmic Events in Brugada SyndromeHeart Rhythm, 2018
- J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledgeHeart Rhythm, 2016
- Impact of clinical and genetic findings on the management of young patients with Brugada syndromeHeart Rhythm, 2016
- Follow-up From Childhood to Adulthood of Individuals With Family History of Brugada Syndrome and Normal ElectrocardiogramsJAMA, 2014
- Life-threatening ventricular arrhythmias during ajmaline challenge in patients with Brugada syndrome: Incidence, clinical features, and prognosisHeart Rhythm, 2013
- An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testingHeart Rhythm, 2010
- Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndromeJACC, 1992